Twist Bioscience Hits Day High with 9.62% Surge in Strong Intraday Performance

Twist Bioscience Corp., a small-cap player in the Pharmaceuticals & Biotechnology sector, has seen significant activity today, gaining 9.62% and reaching an intraday high of USD 96.12. This performance stands out against the S&P 500, which only increased by 0.89% on the same day. Over the past week, Twist Bioscience has shown a 3.6% increase, while its one-month performance reflects a 9.48% rise. Impressively, the stock has surged 175.7% over the past year, significantly outperforming the S&P 500's 19.09% gain. Year-to-date, the stock has achieved a remarkable 202.21% increase, further highlighting its strong market position. Despite its recent successes, the company is trading at a higher risk compared to its historical valuations. The stock's operating cash flow and net sales have reached notable highs, with net sales for the last quarter reported at USD 110.72 million. However, it remains a loss-making entity, reflected in its negative P/E ratio and return on equity. With institutional holdings at 100%, the stock's performance continues to be closely monitored by investors.